Monday, April 13th, 2026

ADB approves $165 million loan for COVID-19 vaccines in Nepal



KATHMANDU: The Asian Development Bank (ADB) Thursday approved a loan of $165 million (equivalent to Rs 19 billion 800 million) for Nepal to purchase safe and effective vaccines against the coronavirus disease (COVID-19).

The project will support the National Deployment and Vaccination Plan in Nepal by procuring an estimated 15.9 million doses of COVID-19 vaccines, which will benefit about 6.8 million Nepalese, according to a press statement issued by the Manila-based ADB Headquarters.

“ADB’s support will help the Government of Nepal procure much-needed COVID-19 vaccines to protect its citizens from the further spread of this disease,” said ADB President Masatsugu Asakawa. The ADB President added: “It is essential that COVID-19 vaccines are quickly purchased and administered to help get the economy back on track by enabling the restoration of livelihoods and economic activities, as well as the resumption of educational and human development pursuits.”

Publish Date : 22 July 2021 20:04 PM

Reminiscing Last Week: A Landscape of Political Flux

The set of developments from the past week reflects a

Economic Digest: Nepal’s Business News in a Snap

KATHMANDU: Economic Digest offers a concise yet comprehensive overview of

US to impose naval blockade on Iranian shipping after talks end without deal

WASHINGTION DC: US President Donald Trump has announced that the

Light rain and thunderstorms likely today

KATHMANDU: The country is currently under the combined influence of

Planned Kaligandaki hydropower project scaled down to 640 MW

KATHMANDU: The proposed Kaligandaki Reservoir Hydropower Project will be developed